Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Feb 20, 2024 (filed on Feb 21, 2024)Insider Name:Muscato NickOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-327Price:$93.69
-
Feb 20, 2024 (filed on Feb 21, 2024)Insider Name:Ginn Scott GOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,218Price:$93.69
-
Feb 20, 2024 (filed on Feb 21, 2024)Insider Name:North Michael PaulOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,591Price:$93.69
-
Feb 20, 2024 (filed on Feb 21, 2024)Insider Name:Bohnert Denise M.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,415Price:$93.69
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:Muscato NickOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,518Price:--
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:Holton Adam YOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,518Price:--
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:Ginn Scott GOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,553Price:--
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:North Michael PaulOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:8,277Price:--
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:Ashworth Richard MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:55,175Price:--
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:Bohnert Denise M.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,518Price:--
Filings by filing date
-
Feb 20, 2024 (filed on Feb 21, 2024)Insider Name:Muscato NickOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-327Price:$93.69
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:Muscato NickOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,518Price:--
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:Holton Adam YOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,518Price:--
-
Feb 20, 2024 (filed on Feb 21, 2024)Insider Name:Ginn Scott GOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,218Price:$93.69
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:Ginn Scott GOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,553Price:--
-
Feb 20, 2024 (filed on Feb 21, 2024)Insider Name:North Michael PaulOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,591Price:$93.69
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:North Michael PaulOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:8,277Price:--
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:Ashworth Richard MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:55,175Price:--
-
Feb 20, 2024 (filed on Feb 21, 2024)Insider Name:Bohnert Denise M.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,415Price:$93.69
-
Feb 16, 2024 (filed on Feb 21, 2024)Insider Name:Bohnert Denise M.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,518Price:--
News
Biz Brief
Sector: Healthcare | Industry: Healthcare Facilities & Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 5959 S SHERWOOD FOREST BLVD BATON ROUGE LA 70816 |
Tel: | 1-855-2592046 |
Website: | https://www.amedisys.com |
IR: | See website |
Key People | ||
Paul B. Kusserow Chairman of the Board | Richard M. Ashworth President, Chief Executive Officer, Director | Scott G. Ginn Chief Financial Officer, Acting Chief Operating Officer, Executive Vice President |
Adam Holton Chief People Officer | Allyson Guidroz Chief Accounting Officer | Michael Paul North Chief Information Officer |
Denise Bohnert Chief Compliance Officer | Nick Muscato Chief Strategy Officer |
Business Overview |
Amedisys, Inc. is a healthcare service company. The Company is engaged in providing care and support in the home. It delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. |
Financial Overview |
For the fiscal year ended 31 December 2023, Amedisys Inc revenues increased 1% to $2.24B. Net loss totaled $9.7M vs. income of $118.6M. Revenues reflect Home Health Care segment increase of 4% to $1.4B, Hospice segment increase of 1% to $798.8M, High Acuity Care segment increase of 3% to $19M. Net loss reflects Other segment loss increase of 39% to $243.1M, Personal care segment income decrease of 70% to $1.6M. |
Employees: | 19,000 as of Feb 16, 2024 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $3,252M as of Dec 31, 2023 |
Annual revenue (TTM): | $2,236M as of Dec 31, 2023 |
EBITDA (TTM): | $196.74M as of Dec 31, 2023 |
Net annual income (TTM): | -$9.75M as of Dec 31, 2023 |
Free cash flow (TTM): | $124.48M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $271.73M as of Dec 31, 2023 |
Shares outstanding: | 32,667,631 as of Feb 16, 2024 |
Index Membership: | S&P 400 Mid Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |